Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 59.67% is 141% above its 5-year average of -145.27%, near the high end of its 5-year range (-557.10%–59.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 572.07% above its 12-month average of 8.88%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
59.67%
RETURN ON EQUITY (ROE) AVG TTM
8.88%
RETURN ON EQUITY (ROE) AVG 3Y
-86.27%
RETURN ON EQUITY (ROE) AVG 5Y
-145.27%
RETURN ON EQUITY (ROE) AVG 10Y
-56.43%
RETURN ON EQUITY (ROE) AVG 15Y
-44.32%
RETURN ON EQUITY (ROE) AVG 20Y
-36.19%
CURRENT VS TTM AVG
+572.07%
CURRENT VS 3Y AVG
+169.17%
CURRENT VS 5Y AVG
+141.07%
CURRENT VS 10Y AVG
+205.73%
CURRENT VS 15Y AVG
+234.62%
CURRENT VS 20Y AVG
+264.89%
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
+421.58%
vs the sector median at left
Alnylam Pharmaceuticals, Inc.
Market Cap
$31.73B
Return on Equity (ROE)
59.67%
TTM Avg
8.88%
3Y Avg
-86.27%
5Y Avg
-145.27%
Market Cap
$31.99B
Return on Equity (ROE)
-22.60%
TTM Avg
-10.46%
3Y Avg
-1.37%
5Y Avg
1.10%
Market Cap
$32.28B
Return on Equity (ROE)
4.43%
TTM Avg
8.42%
3Y Avg
11.86%
5Y Avg
16.52%
Market Cap
$32.40B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$32.42B
Return on Equity (ROE)
83.10%
TTM Avg
66.19%
3Y Avg
56.82%
5Y Avg
52.60%
Market Cap
$31.02B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$29.83B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
Market Cap
$34.27B
Return on Equity (ROE)
38.14%
TTM Avg
28.93%
3Y Avg
25.01%
5Y Avg
22.95%
Market Cap
$34.86B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | $31.73B | 59.67% | 8.88% | -86.27% | -145.27% |
| Centene Corp. (CNC)vs › | $31.99B | -22.60% | -10.46% | -1.37% | 1.10% |
| Biogen Inc. (BIIB)vs › | $32.28B | 4.43% | 8.42% | 11.86% | 16.52% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.40B | 14.51% | 21.84% | 21.53% | 32.27% |
| Zoetis Inc. (ZTS)vs › | $32.42B | 83.10% | 66.19% | 56.82% | 52.60% |
| Waters Corporation (WAT)vs › | $31.02B | 1.09% | 29.98% | 64.02% | 111.55% |
| Medline Inc. (MDLN)vs › | $29.83B | 5.97% | 9.02% | 4.86% | 4.86% |
| DexCom, Inc. (DXCM)vs › | $34.27B | 38.14% | 28.93% | 25.01% | 22.95% |
| ResMed Inc. (RMD)vs › | $34.86B | 23.13% | 23.30% | 22.33% | 21.49% |
| Alcon Inc. (ALC)vs › | $35.12B | 2.96% | 4.58% | 3.90% | 2.45% |
ROE
59.7%
ROA
14.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 59.67% |
| 2026-03-31 | 53.68% |
| 2025-12-31 | 39.76% |
| 2025-09-30 | 18.63% |
| 2025-06-30 | -127.33% |
| 2025-03-31 | -233.64% |
| 2024-12-31 | -414.62% |
| 2022-06-30 | -557.10% |
| 2022-03-31 | -222.57% |
| 2021-12-31 | -144.99% |
| 2021-09-30 | -110.85% |
| 2021-06-30 | -103.90% |
| 2021-03-31 | -94.62% |
| 2020-12-31 | -84.46% |
| 2020-09-30 | -73.33% |
| 2020-06-30 | -60.45% |
| 2020-03-31 | -65.67% |
| 2019-12-31 | -61.59% |
| 2019-09-30 | -51.11% |
| 2019-06-30 | -48.83% |
| 2019-03-31 | -51.86% |
| 2018-12-31 | -58.49% |
| 2018-09-30 | -46.84% |
| 2018-06-30 | -35.16% |
| 2018-03-31 | -29.91% |
| 2017-12-31 | -27.79% |
| 2017-09-30 | -43.59% |
| 2017-06-30 | -39.42% |
| 2017-03-31 | -49.88% |
| 2016-12-31 | -44.57% |
| 2016-09-30 | -38.22% |
| 2016-06-30 | -32.83% |
| 2016-03-31 | -28.79% |
| 2015-12-31 | -22.94% |
| 2015-09-30 | -16.70% |
| 2015-06-30 | -13.34% |
| 2015-03-31 | -10.71% |
| 2014-12-31 | -38.49% |
| 2014-09-30 | -41.06% |
| 2014-06-30 | -37.89% |
| 2014-03-31 | -34.68% |
| 2013-12-31 | -33.00% |
| 2013-09-30 | -40.01% |
| 2013-06-30 | -35.33% |
| 2013-03-31 | -33.27% |
| 2012-12-31 | -79.08% |
| 2012-09-30 | -32.81% |
| 2012-06-30 | -27.55% |
| 2012-03-31 | -26.72% |
| 2011-12-31 | -48.86% |
| 2011-09-30 | -39.32% |
| 2011-06-30 | -34.18% |
| 2011-03-31 | -32.62% |
| 2010-12-31 | -27.50% |
| 2010-09-30 | -27.62% |
| 2010-06-30 | -26.56% |
| 2010-03-31 | -30.28% |
| 2009-12-31 | -26.74% |
| 2009-09-30 | -27.02% |
| 2009-06-30 | -23.22% |
| 2009-03-31 | -16.55% |
| 2008-12-31 | -12.99% |
| 2008-09-30 | -7.43% |
| 2008-06-30 | -32.70% |
| 2008-03-31 | -32.08% |
| 2007-12-31 | -42.91% |
| 2007-09-30 | -49.53% |
| 2007-06-30 | -27.99% |
| 2007-03-31 | -24.94% |
| 2006-12-31 | -17.20% |
| 2006-09-30 | -38.81% |
| 2006-06-30 | -39.92% |
| 2006-03-31 | -38.31% |
| 2005-12-31 | -69.46% |
| 2005-09-30 | -147.90% |
| 2005-06-30 | -101.61% |
| 2005-03-31 | -64.46% |
| 2004-12-31 | -70.77% |
| 2004-09-30 | -73.84% |
| 2004-06-30 | -65.23% |
